IGC Pharma, Inc.
IGCHealthcare|Biotechnology|US
$0.20
+0.01 (+5.82%)
Tangible Book / Share
$0.01
Cash / Share
$0.00
Clinical Trials (2)
| Trial | Conditions | Phase | Status | Enrollment | Design | Drug |
|---|---|---|---|---|---|---|
| NCT05543681 Clinical Trial on Agitation in Alzheimer's Dementia | Alzheimer Disease, Agitation,Psychomotor | P2 | Active | 164 | RCT, Double-blind | IGC-AD1-Active, IGC-AD1-Placebo |
| NCT04749563 Study of IGC-AD1 in Subjects With Dementia Due to Alzheimer's Disease | Dementia of Alzheimer Type | P1 | Completed | 12 | RCT, Double-blind | IGC AD1, Placebo |